News
Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback